Cymbalta Class Action

A class action is a type of lawsuit in which a number of plaintiffs join together to sue a common defendant responsible for their harm. Class actions require approval from a judge who makes certain the class action will adequately address the injuries suffered by each plaintiff. Class actions are routine in actions against large drug corporations and are becoming increasingly common with regard to the anti-depressant drug Cymbalta. Former Cymbalta users across the United States are asserting their legal rights against the drug maker for failing to adequately warn about the likelihood of the onset of suicidal thoughts or tendencies upon discontinuation of this drug. Known as Cymbalta Discontinuation Syndrome, members of class actions are suing Eli Lily for medical expenses or lost wages incurred as a result of suffering from the withdrawal effects and subsequent additional treatment needed to combat the symptoms. For more information about a Cymbalta class action lawsuit, contact a Cymbalta lawyer right away.

Contact Cymbalta Attorneys

Cymbalta LawyersOur firms are investigating problems with symptoms from the discontinuation of use of Cymbalta. Please use the form below to tell us about your situation. We will contact you by phone as soon as possible.

Your confidentiality matters. No information, including phone numbers and email addresses will be exchanged, shared or sold to a third party. Any communications to our firm via contact forms, email, phone or U.S. mail, will be treated confidentially. Submissions are made for the purpose of evaluating whether or not our law firm will accept your case and represent you. However, all information contained in your submission will be held confidential. By evaluating your submission we make no representation or agreement to represent you in connection with your claim. Thank you.

Please type your full street address including your city, state and postal code
Approximate date Cymbalta was prescribed to you
Approximate date you stopped using Cymbalta
Subscribe to Cymbalta Class Action RSS